Page last updated: 2024-11-05

thiotepa and Corneal Angiogenesis

thiotepa has been researched along with Corneal Angiogenesis in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROCK, RL1
LAVERGNE, G1
COLMANT, IA1

Other Studies

2 other studies available for thiotepa and Corneal Angiogenesis

ArticleYear
Inhibition of corneal vascularization by triethylene thiophosphoramide (Thio-Tepa).
    Archives of ophthalmology (Chicago, Ill. : 1960), 1963, Volume: 69

    Topics: Corneal Neovascularization; Corneal Transplantation; Humans; Thiotepa

1963
COMPARATIVE STUDY OF THE ACTION OF THIOTEPA AND TRIAMCINOLONE ON CORNEAL VASCULARIZATION IN RABBITS.
    The British journal of ophthalmology, 1964, Volume: 48

    Topics: Animals; Blood Vessels; Cautery; Cell Division; Cornea; Corneal Neovascularization; Corneal Opacity;

1964